Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.

Gawde KA, Sau S, Tatiparti K, Kashaw SK, Mehrmohammadi M, Azmi AS, Iyer AK.

Colloids Surf B Biointerfaces. 2018 Jul 1;167:8-19. doi: 10.1016/j.colsurfb.2018.03.046. Epub 2018 Mar 28.

PMID:
29625422
2.

A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.

Sau S, Tatiparti K, Alsaab HO, Kashaw SK, Iyer AK.

Drug Discov Today. 2018 Jul;23(7):1344-1356. doi: 10.1016/j.drudis.2018.03.003. Epub 2018 Mar 15. Review.

PMID:
29551455
3.
4.

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.

Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw SK, Iyer AK.

Front Pharmacol. 2017 Aug 23;8:561. doi: 10.3389/fphar.2017.00561. eCollection 2017. Review.

5.

Advances in antibody-drug conjugates: A new era of targeted cancer therapy.

Sau S, Alsaab HO, Kashaw SK, Tatiparti K, Iyer AK.

Drug Discov Today. 2017 Oct;22(10):1547-1556. doi: 10.1016/j.drudis.2017.05.011. Epub 2017 Jun 13. Review.

PMID:
28627385
6.

siRNA Delivery Strategies: A Comprehensive Review of Recent Developments.

Tatiparti K, Sau S, Kashaw SK, Iyer AK.

Nanomaterials (Basel). 2017 Apr 5;7(4). pii: E77. doi: 10.3390/nano7040077. Review.

Supplemental Content

Loading ...
Support Center